Professional Development
Emerging Therapies in Chronic Kidney Disease in Patients with Type 2 Diabetes
Recurring Event
daily, starting from Friday, February 24th, 2023 - 12:00 PM, one time
-Identify patients with residual risk for renal and CV events despite optimized standard of care
-Review new agents in CKD with T2D such as SGLT2 inhibitors and non-steroidal MRAs
-Practical considerations when initiating these new therapies
-Review new agents in CKD with T2D such as SGLT2 inhibitors and non-steroidal MRAs
-Practical considerations when initiating these new therapies
Presenter: Dr. Karthik Tennankore
This group learning has been certified by the College of Family Physicians of Canada and awards 1 Mainpro+ certified credit